Literature DB >> 17658523

Uterine myomas: management.

William H Parker1.   

Abstract

OBJECTIVE: To review the currently available literature regarding the current management alternatives available to women with uterine myomas.
DESIGN: Literature review of 198 articles pertaining to uterine myomas. RESULT(S): Many advances have been made in the management of uterine myomas. Watchful waiting; medical therapy; hysteroscopic myomectomy; endometrial ablation; laparoscopic myomectomy; abdominal myomectomy; abdominal, vaginal, and laparoscopic hysterectomy; uterine artery embolization; uterine artery occlusion; and focused ultrasound are now available. CONCLUSION(S): Many options are now available to women with uterine myomas. The presently available literature regarding the treatment of myomas is summarized.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658523     DOI: 10.1016/j.fertnstert.2007.06.044

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  47 in total

1.  The use of novel hemostatic sealant (Tisseel) in laparoscopic myomectomy: a case-control study.

Authors:  Roberto Angioli; Francesco Plotti; Roberto Ricciardi; Corrado Terranova; Marzio Angelo Zullo; Patrizio Damiani; Roberto Montera; Federica Guzzo; Giuseppe Scaletta; Ludovico Muzii
Journal:  Surg Endosc       Date:  2012-02-01       Impact factor: 4.584

2.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

3.  Diffusion-weighted magnetic resonance imaging using different b-value combinations for the evaluation of treatment results after volumetric MR-guided high-intensity focused ultrasound ablation of uterine fibroids.

Authors:  Marlijne E Ikink; Marianne J Voogt; Maurice A A J van den Bosch; Robbert J Nijenhuis; Bilgin Keserci; Young-sun Kim; Koen L Vincken; Lambertus W Bartels
Journal:  Eur Radiol       Date:  2014-06-25       Impact factor: 5.315

Review 4.  Reproductive tract function and dysfunction in women.

Authors:  Angshumoy Roy; Martin M Matzuk
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

5.  How should painful cystic degeneration of myomas be managed during pregnancy? a case report and review of the literature.

Authors:  Tae-Hee Kim; Hae-Hyeog Lee
Journal:  Iran J Reprod Med       Date:  2011

6.  Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET.

Authors:  Yoshio Yoshida; Yasushi Kiyono; Tetsuya Tsujikawa; Tetsuji Kurokawa; Hidehiko Okazawa; Fumikazu Kotsuji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-08       Impact factor: 9.236

7.  Barrier methods used to prevent pelvic adhesions in videolaparoscopy: experimental study in female rabbits.

Authors:  Rosi P Balbinotto; Ana L Muller; André G Nunes; Rodrigo Da Silva; Fabíola S Meyer; Carlos S Cerski; Manoel M Trindade
Journal:  Surg Endosc       Date:  2011-03-17       Impact factor: 4.584

8.  Fibroid-associated heavy menstrual bleeding: correlation between clinical features, Doppler ultrasound assessment of vasculature, and tissue gene expression profiles.

Authors:  Sophia E Tsiligiannis; Marina Zaitseva; Peter R Coombs; Paul Shekleton; Moshe Olshansky; Martha Hickey; Beverley Vollenhoven; Peter A W Rogers
Journal:  Reprod Sci       Date:  2012-09-20       Impact factor: 3.060

9.  Evaluating risk factors for differences in fibroid size and number using a large electronic health record population.

Authors:  Michael J Bray; Eric S Torstenson; Sarah H Jones; Todd L Edwards; Digna R Velez Edwards
Journal:  Maturitas       Date:  2018-05-11       Impact factor: 4.342

10.  Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice.

Authors:  Dong Zhang; Mohamed Al-Hendy; Gloria Richard-Davis; Valerie Montgomery-Rice; Chakradhari Sharan; Veera Rajaratnam; Anjali Khurana; Ayman Al-Hendy
Journal:  Am J Obstet Gynecol       Date:  2010-01-13       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.